ProfileGDS4718 / 244619_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 20% 22% 22% 24% 26% 29% 24% 26% 25% 30% 18% 27% 26% 22% 26% 18% 23% 28% 26% 34% 27% 17% 23% 17% 19% 27% 23% 24% 19% 30% 29% 25% 30% 19% 18% 21% 23% 28% 24% 12% 24% 24% 26% 16% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1609520
GSM549102patient 115, normal, homogenized [OPG study]4.2206322
GSM549104patient 119, normal, homogenized [OPG study]4.1810322
GSM549108patient 138, normal, homogenized [OPG study]4.3227924
GSM549119patient 077, normal, homogenized [OPG study]4.3931126
GSM549133patient 032, cancer, homogenized [OPG study]4.4423129
GSM549139patient 042, cancer, homogenized [OPG study]4.2711124
GSM549099patient 107, normal, homogenized [OPG study]4.3932826
GSM549109patient 139, normal, homogenized [OPG study]4.3621325
GSM549110patient 046, normal, homogenized [OPG study]4.5287730
GSM549114patient 063, normal, homogenized [OPG study]4.0335218
GSM549122patient 082, normal, homogenized [OPG study]4.425227
GSM549134patient 033, cancer, homogenized [OPG study]4.3741626
GSM549136patient 036, cancer, homogenized [OPG study]4.1587622
GSM549140patient 044, cancer, homogenized [OPG study]4.3183626
GSM549111patient 047, normal, homogenized [OPG study]4.0291518
GSM549113patient 057, normal, homogenized [OPG study]4.1876923
GSM549132patient 031, cancer, homogenized [OPG study]4.4300828
GSM549137patient 038, cancer, homogenized [OPG study]4.3423826
GSM549142patient 047, cancer, homogenized [OPG study]4.8485934
GSM549100patient 110, normal, homogenized [OPG study]4.4446527
GSM549107patient 135, normal, homogenized [OPG study]4.0091617
GSM549115patient 068, normal, homogenized [OPG study]4.2015923
GSM549116patient 072, normal, homogenized [OPG study]4.0282317
GSM549120patient 078, normal, homogenized [OPG study]4.0856319
GSM549131patient 030, cancer, homogenized [OPG study]4.3633327
GSM549118patient 074, normal, homogenized [OPG study]4.2787823
GSM549129patient 027, cancer, homogenized [OPG study]4.3237124
GSM549123patient 088, normal, homogenized [OPG study]4.1084219
GSM549124patient 006, cancer, homogenized [OPG study]4.5920130
GSM549126patient 015, cancer, homogenized [OPG study]4.4989629
GSM549128patient 025, cancer, homogenized [OPG study]4.3328825
GSM549103patient 117, normal, homogenized [OPG study]4.579230
GSM549117patient 073, normal, homogenized [OPG study]4.0994919
GSM549138patient 041, cancer, homogenized [OPG study]4.0600718
GSM549141patient 045, cancer, homogenized [OPG study]4.1306421
GSM549130patient 028, cancer, homogenized [OPG study]4.2796123
GSM549101patient 111, normal, homogenized [OPG study]4.4811228
GSM549105patient 128, normal, homogenized [OPG study]4.3345824
GSM549106patient 134, normal, homogenized [OPG study]3.8216812
GSM549112patient 048, normal, homogenized [OPG study]4.2948424
GSM549125patient 011, cancer, homogenized [OPG study]4.3031224
GSM549127patient 024, cancer, homogenized [OPG study]4.3467326
GSM549135patient 035, cancer, homogenized [OPG study]3.951716